Speciality Medi.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
163.05
7.75 (4.99%)
BSENSE

Apr 13

BSE+NSE Vol: 15000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

15.0 k (-82.06%) Volume

Shareholding (Mar 2026)

FII

0.24%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

43.43%

Why is Speciality Medi. falling/rising?

13-Apr-2026

As of 12-Apr, Speciality Medicines Ltd's stock price is rising to Rs. 155.30, reflecting a 4.97% increase. This rise is driven by a positive trend over the past week, strong relative performance, and trading above key moving averages, despite a significant drop in investor participation.

As of 12-Apr, Speciality Medicines Ltd's stock price is rising, currently at Rs. 155.30, which reflects an increase of Rs. 7.35 or 4.97%. This upward movement can be attributed to several key factors. Firstly, the stock has been on a positive trend, gaining for the last seven consecutive days and achieving a total return of 23.35% during this period. Additionally, it opened today with a gain of 4.97%, reaching a new 52-week and all-time high of Rs. 155.30.<BR><BR>The stock has also outperformed its sector by 4.68%, indicating strong relative performance. Furthermore, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is often seen as a bullish signal. However, it is worth noting that there has been a significant decline in investor participation, with delivery volume dropping by 92.54% compared to the 5-day average. Despite this decrease in participation, the overall positive price movement and performance metrics suggest that the stock is currently experiencing a rise.

View full answer

Which are the latest news on Speciality Medi.?

13-Apr-2026
No latest news for Speciality Medi. found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 143 Cr ()

stock-summary
P/E

16.00

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

4.49

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Closure of Trading Window

31-Mar-2026 | Source : BSE

We hereby submit the Intimation of Closure of Trading Window for insiders of the Company.

Listing of Equity Shares of Speciality Medicines Ltd

30-Mar-2026 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from March 30 2026 the Equity Shares of Speciality Medicines Ltd (Scrip Code: 544738) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260327- dated March 27 2026.

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
16
Industry P/E
32
Price to Book Value
4.49
EV to EBIT
15.68
EV to EBITDA
15.34
EV to Capital Employed
4.18
EV to Sales
2.39
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.64%
ROE (Latest)
28.31%

Technicals key factors

Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.24%)

Promoter with highest holding

Parthkumar Babulal Goyani (21.12%)

Highest Public shareholder

Aparna Samir Thakker (7.33%)

Individual Investors Holdings

48.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Speciality Medi."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Speciality Medi."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Speciality Medi."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Speciality Medi."
  }
]
stock-summaryCompany CV
About Speciality Medicines Ltd stock-summary
stock-summary
Speciality Medicines Ltd
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available